| | |
| | | Eisai Golden Ticket Open for Submissions
Eisai is interested in drug discovery platform technologies, novel targets, and biology that can be utilized in oncology and neurology.
APPLY by September 4 ► |
|
|
|
|
|
|
|
|
|
|
|
| | AbbVie Golden Ticket Open for Submissions
The program is designed for individuals who may be earlier in their careers or have had limited access to industry networks, startup experience or the broader life sciences innovation ecosystem.
APPLY by October 2 ► |
|
|
|
|
|
|
|
|
|
|
|
| | Ono Golden Ticket Winner Announcement
Congratulations to ASERTI Pharmaceutical on being selected for the 2026 Ono Golden Ticket. We can't wait to see where your work on a novel approach to targeted protein regulation takes you—reaching vital targets across oncology, immunology, and beyond!
LEARN MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Farewell, Flavia Nachbar
Recently we said farewell to our beloved Director of Alliances, Flavia Nachbar. During her time at MBC Biolabs, Flavia has been instrumental in building our alliance program to more than 60 partners across our campuses. Flavia’s relationship-building and networking talents have made a lasting impact on our community. We’ll miss her dearly and are excited to see all she accomplishes in this next chapter.
Congratulations and best wishes, Flavia! |
|
|
|
|
|
|
|
|
|
|
|
| | | | | From Setup to Screening – Streamlined Workflows with the ID7000™ Spectral Cell Analyzer
September 10 @ 12pm - 1pm
1030 Brittan Ave, San Carlos
Join us for an informative session where we’ll highlight practical tools designed to improve operational efficiency, enhance fluorescence signal quality, and expand analysis capabilities across a broad range of cell sizes.
REGISTER ► |
|
|
| | Thermo Fisher Mass Spec Symposium @MBC Biolabs
September 14 @ 9am - 1pm
1030 Brittan Ave, San Carlos
Join us for a morning of mass spectrometry innovation, practical workflows, and emerging applications spanning sample preparation, quantitative proteomics, structural biology, and biopharmaceutical research.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
| | State of the Venture Capital Financing Market (Day 1 of 2)
September 22 @ 12pm - 1pm
1030 Brittan Ave, San Carlos
Please join us for a discussion of the current state of the venture capital market financing and a Q&A session with VCs from the Bay Area life sciences community.
REGISTER ► |
|
|
| | State of the Venture Capital Financing Market (Day 2 of 2)
September 23 @ 12pm - 1pm
135 Mississippi St, San Francisco
Please join us for a discussion of the current state of the venture capital market financing and a Q&A session with VCs from the Bay Area life sciences community.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
| | Reveal More with Automated Sample Prep Applications: AssayMAP Bravo
October 15 @ 12pm - 1pm
1030 Brittan Ave, San Carlos
This presentation will explore how automation can improve data quality, reduce errors, increase laboratory efficiency, and support seamless assay transfer between research, development, and quality control laboratories.
REGISTER ► |
|
|
| | From Planning, Prompting, to Pipetting - How to Utilise Opentrons AI for Lab Automation
October 28 @ 12pm - 1pm
1030 Brittan Ave, San Carlos
REGISTER ►
October 29 @ 12pm - 1pm
953 Indiana St, San Francisco
REGISTER ►
Join Opentrons for a Lunch & Learn demonstrating Opentrons AI for generating scripts used in Flex and OT-2 Lab automation.
|
|
|
|
|
|
|
|
|
|
|
|
| | | | | Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery
Funding will expand Opal’s uterine-organoid platform and predictive uterine data atlas to overcome historical preclinical bottlenecks in endometriosis and fibroid research
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Dispatch Bio Announces First Patient Dosed in Phase 1 Study of DISP-10, a Novel Investigational Immunotherapy, in Advanced Gastrointestinal (GI) Cancers
Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced the first participant has been dosed in a Phase 1 clinical trial evaluating the safety and efficacy of DISP-10 in adult participants with advanced gastrointestinal (GI) cancers, including colorectal cancer, gastric adenocarcinoma, esophageal adenocarcinoma, and gastroesophageal adenocarcinoma.
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Switch Bioworks Advances Novel Microbial Fertilizer Into First-In-Class Field Trials
Amid global concern over rising fertilizer costs, supply chain fragility, and environmental impact, Switch Bioworks advances field trials of a new generation of fertilizer produced by living microbes directly on plant roots
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Delve Bio featured in the New Yorker: Stumped by a Medical Mystery? Try Metagenomics
When doctors can’t figure out what’s ailing us, they can search our bodies for snippets of genetic material from viruses, bacteria, and fungi.
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | | | | Fragrance: The Invisible Signature
September 2 @ 4:30pm - 6pm
San Francisco
A panel discussion exploring the art and science of fragrance, how biology shapes what we smell, and where new opportunities are for personalized wellness. Guest perfumer Albert Ching will unveil an original fragrance, share the thinking and creative process behind its design, and invite guests to experience a selection of new scents.
REGISTER ► |
|
|
| | Gladstone × MBC BioLabs: From Discovery to Startup
September 8 @ 4pm - 6:30pm
San Francisco
Join us for an evening of networking at MBC BioLabs, a local life sciences startup incubator that’s helped launch over 500 companies! This is a great opportunity to tour the space, hear from founders who’ve made the jump from the lab to startup life, and connect with the local biotech community over beverages.
This event is sold out and no longer taking registrations. |
|
|
|
|
|
|
|
|
|
|
|
| | Innovation in the Circular Bioeconomy: From Waste to Fuels and Climate Solutions
September 10 @ 5:30pm - 7:30pm
San Carlos
REGISTER ►
We are pleased to invite you to the 23rd edition of the NEDO Silicon Valley Foresight Series, exploring the rapidly advancing field of the Circular Bioeconomy and how biotechnology and innovative business models are transforming waste into valuable resources, sustainable fuels, and climate solutions. |
|
|
| | Hops & Ops: Biotech Operators Happy Hour
September 17 @ 6pm - 7:30pm
San Francisco
REGISTER ►
Join us for a relaxed happy hour bringing together biotech operators to swap stories, share ideas, and connect with others building in the space. Whether you're scaling teams, streamlining operations, or navigating the day-to-day of building in biotech, this is your space to connect with others in the trenches. Enjoy complimentary food and drinks and toast to shared challenges and wins. |
|
|
|
|
|
|
|
|
|
|
|
| | MBC BioLabs Immunology Innovation Forum
September 24 @ 3pm - 7:30pm
1030 Brittan Ave, San Carlos
REGISTER ►
This Innovation Forum brings together the founders directing the immune system against disease, and correcting when it turns on the body itself. Join us as well bring together the immunology startup community, deepening the ties among the founders, executives, and investors in our ecosystem. |
|
|
| | Founders at Work: Synthetic Design Lab
September 30 @ 12pm - 1pm
1030 Brittan Ave, San Carlos
REGISTER ►
Daniel Chen, PhD, MD Founder & CEO - A pioneer in the field of cancer immuno-therapy and protein engineering and co-author of the Cancer Immunity Cycle, Dr. Chen is an experienced physician-scientist, key opinion leader, drug developer, and entrepreneur. |
|
|
|
|
|
|
|
|
|
|
|
| | | | | Catalyzing Medicine: How Ridge Bio is Building Better Bioconjugates
Ridge Biotechnologies designs enzymes and targeted therapeutics that enable the next generation of precision medicines. The company's labs are based at an MBC site in San Carlos, and in 2025 Ridge announced an oversubscribed $25 million seed round led by Sutter Hill Ventures.
We sat down with CEO and co-founder Weston Kightlinger to learn how the company's platform works, the problem it solves, and what's next.
READ MORE ► |
|
| | | | | | |
|
|
|
| |
|
